Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Neautus Traditional Chinese Herb is a leading Chinese enterprise specializing in the research, development, production, and sale of Traditional Chinese Medicine (TCM) decoction pieces. Founded in 2001 and headquartered in Chengdu, the company operates large-scale GMP-certified manufacturing facilities and maintains extensive herbal cultivation bases. Neautus is recognized for its standardization of TCM processing and its "New Lotus" brand, which supplies hospitals and pharmacies across China and international markets. The company's product portfolio includes over 1,000 varieties of processed herbal medicines, focusing on quality control and traceability from cultivation to final product. Through its commitment to modernization, Neautus has become a key contributor to the industrialization of traditional herbal therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Neautus Traditional Chinese Herb.